These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

608 related items for PubMed ID: 8524800

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. E2F4-RB and E2F4-p107 complexes suppress gene expression by transforming growth factor beta through E2F binding sites.
    Li JM, Hu PP, Shen X, Yu Y, Wang XF.
    Proc Natl Acad Sci U S A; 1997 May 13; 94(10):4948-53. PubMed ID: 9144170
    [Abstract] [Full Text] [Related]

  • 3. Structure of the Rb C-terminal domain bound to E2F1-DP1: a mechanism for phosphorylation-induced E2F release.
    Rubin SM, Gall AL, Zheng N, Pavletich NP.
    Cell; 2005 Dec 16; 123(6):1093-106. PubMed ID: 16360038
    [Abstract] [Full Text] [Related]

  • 4. Disruption of retinoblastoma protein function by coexpression of its C pocket fragment.
    Welch PJ, Wang JY.
    Genes Dev; 1995 Jan 01; 9(1):31-46. PubMed ID: 7828850
    [Abstract] [Full Text] [Related]

  • 5. Formation of the early-region-2 transcription-factor-1-retinoblastoma-protein (E2F-1-RB) transrepressor and release of the retinoblastoma protein from nuclear complexes containing cyclin A is induced by interferon alpha in U937V cells but not in interferon-alpha-resistant U937VR cells.
    Kirch HC, Putzer B, Brockmann D, Esche H, Kloke O.
    Eur J Biochem; 1997 Jun 15; 246(3):736-44. PubMed ID: 9219533
    [Abstract] [Full Text] [Related]

  • 6. Growth suppression by an E2F-binding-defective retinoblastoma protein (RB): contribution from the RB C pocket.
    Whitaker LL, Su H, Baskaran R, Knudsen ES, Wang JY.
    Mol Cell Biol; 1998 Jul 15; 18(7):4032-42. PubMed ID: 9632788
    [Abstract] [Full Text] [Related]

  • 7. The transcription factor E2F-1 is a downstream target of RB action.
    Qin XQ, Livingston DM, Ewen M, Sellers WR, Arany Z, Kaelin WG.
    Mol Cell Biol; 1995 Feb 15; 15(2):742-55. PubMed ID: 7823942
    [Abstract] [Full Text] [Related]

  • 8. E1A 12S and 13S of the transformation-defective adenovirus type 12 strain CS-1 inactivate proteins of the RB family, permitting transactivation of the E2F-dependent promoter.
    Pützer BM, Rumpf H, Rega S, Brockmann D, Esche H.
    J Virol; 1997 Dec 15; 71(12):9538-48. PubMed ID: 9371617
    [Abstract] [Full Text] [Related]

  • 9. Structural basis for the recognition of the E2F transactivation domain by the retinoblastoma tumor suppressor.
    Lee C, Chang JH, Lee HS, Cho Y.
    Genes Dev; 2002 Dec 15; 16(24):3199-212. PubMed ID: 12502741
    [Abstract] [Full Text] [Related]

  • 10. Mechanism of active transcriptional repression by the retinoblastoma protein.
    Weintraub SJ, Chow KN, Luo RX, Zhang SH, He S, Dean DC.
    Nature; 1995 Jun 29; 375(6534):812-5. PubMed ID: 7596417
    [Abstract] [Full Text] [Related]

  • 11. E2F-1-mediated transactivation is inhibited by complex formation with the retinoblastoma susceptibility gene product.
    Flemington EK, Speck SH, Kaelin WG.
    Proc Natl Acad Sci U S A; 1993 Aug 01; 90(15):6914-8. PubMed ID: 8346196
    [Abstract] [Full Text] [Related]

  • 12. Retinoblastoma-repression of E2F-dependent transcription depends on the ability of the retinoblastoma protein to interact with E2F and is abrogated by the adenovirus E1A oncoprotein.
    Arroyo M, Raychaudhuri P.
    Nucleic Acids Res; 1992 Nov 25; 20(22):5947-54. PubMed ID: 1461728
    [Abstract] [Full Text] [Related]

  • 13. Identification of distinct roles for separate E1A domains in disruption of E2F complexes.
    Ikeda MA, Nevins JR.
    Mol Cell Biol; 1993 Nov 25; 13(11):7029-35. PubMed ID: 8413292
    [Abstract] [Full Text] [Related]

  • 14. Differential specificity for binding of retinoblastoma binding protein 2 to RB, p107, and TATA-binding protein.
    Kim YW, Otterson GA, Kratzke RA, Coxon AB, Kaye FJ.
    Mol Cell Biol; 1994 Nov 25; 14(11):7256-64. PubMed ID: 7935440
    [Abstract] [Full Text] [Related]

  • 15. RB and hbrm cooperate to repress the activation functions of E2F1.
    Trouche D, Le Chalony C, Muchardt C, Yaniv M, Kouzarides T.
    Proc Natl Acad Sci U S A; 1997 Oct 14; 94(21):11268-73. PubMed ID: 9326598
    [Abstract] [Full Text] [Related]

  • 16. Transient accumulation of retinoblastoma/E2F-1 protein complexes correlates with the onset of neuronal differentiation in the developing quail neural retina.
    Kastner A, Espanel X, Brun G.
    Cell Growth Differ; 1998 Oct 14; 9(10):857-67. PubMed ID: 9790497
    [Abstract] [Full Text] [Related]

  • 17. RBP1 induces growth arrest by repression of E2F-dependent transcription.
    Lai A, Marcellus RC, Corbeil HB, Branton PE.
    Oncogene; 1999 Mar 25; 18(12):2091-100. PubMed ID: 10321733
    [Abstract] [Full Text] [Related]

  • 18. E2F-dependent regulation of human MYC: trans-activation by cyclins D1 and A overrides tumour suppressor protein functions.
    Oswald F, Lovec H, Möröy T, Lipp M.
    Oncogene; 1994 Jul 25; 9(7):2029-36. PubMed ID: 8208548
    [Abstract] [Full Text] [Related]

  • 19. E2F-Rb complexes assemble and inhibit cdc25A transcription in cervical carcinoma cells following repression of human papillomavirus oncogene expression.
    Wu L, Goodwin EC, Naeger LK, Vigo E, Galaktionov K, Helin K, DiMaio D.
    Mol Cell Biol; 2000 Oct 25; 20(19):7059-67. PubMed ID: 10982822
    [Abstract] [Full Text] [Related]

  • 20. Differential activities of E2F family members: unique functions in regulating transcription.
    Pierce AM, Schneider-Broussard R, Philhower JL, Johnson DG.
    Mol Carcinog; 1998 Jul 25; 22(3):190-8. PubMed ID: 9688145
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.